Navigation Links
CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services, Upcoming Webinar Hosted by Xtalks
Date:6/19/2020

Join experts from Envigo Lauren Klaskala, Project Manager – Custom Transgenic Models and Justin Zhao, PhD, Principal Scientist in a live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK).

Nuclease-based technologies such as CRISPR and ZFN have simplified the way we genetically engineer new models. However, while modifying the genome may be more straightforward, the challenge to create an optimal model for the desired application remains. Creating reliable animal models for long-term studies can often be problematic, not necessarily due to the complexity of the genetic modification(s) required, but with how that genetic modification will perform in the model. Suboptimal design strategies can compound these challenges by generating undesired genotypic or phenotypic results thus producing an ineffective model.

CRISPR-Cas9 or zinc-finger nuclease (ZFN)-based technologies can circumvent the challenges of complex genetic alterations due to their precision. When focusing on what the exact need or application will be for the model, optimal designs can be determined that then yield a reliable model for its specific application. Whether the modification to be produced is a humanization, replacement, conditional knockout, constitutive knockout, large deletion, point mutation, cDNA insertion, or reporter tagging, if careful consideration is given to the goal for the model usage and application, then optimal designs yield superior models.

When considering new model creation and development, scientists often focus on generating the model itself and overlook the downstream services required afterward, including initial model characterization, cryopreservation, breeding, and colony expansion. Envigo is the scientist alongside their customers – taking in all considerations for the model application and all the products and services needed to create, develop, and maintain the model.

For more information or to register for this event, visit CRISPR Generated Models: A Framework for Reducing Risk and Timelines Through Careful Design and Planning for Downstream Services.

ABOUT ENVIGO

Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. Read more at envigo.com.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Sydney Perelmutter
Tel: +1 (416) 977-6555 x 352
Email: sperelmutter@xtalks.com

Read the full story at https://www.prweb.com/releases/crispr_generated_models_a_framework_for_reducing_risk_and_timelines_through_careful_design_and_planning_for_downstream_services_upcoming_webinar_hosted_by_xtalks/prweb17201574.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Shortening guide RNA markedly improves specificity of CRISPR-Cas nucleases
2. CRISPR system can promote antibiotic resistance
3. CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library
4. Plum Alley Closes $1.5M in Syndicate with Women and Men Investing in CRISPR-based Diagnostics Company
5. Horizon Discovery Presents an Educational Webinar on CRISPR-Cas9 Genome Engineering in Primary T cells
6. Asymmetrex Suggests a Stemgene Relief from Recent Cancer Woes About CRISPR-Cas9 Gene-Editing Therapies
7. CRISPR Cas9 Genome Editing Market Worth $5.3 Billion by 2025
8. CRISPR-Chip Enables Digital Detection of DNA without Amplification
9. Book explores place-based conservation as framework
10. New framework to deliver biodiversity knowledge
11. Researchers at Penn show optimal framework for heartbeats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2020)... (PRWEB) , ... June 09, 2020 , ... Superior ... custom industrial automation and IT solutions for the life sciences industry, is pleased to ... Business Development working out of the company’s Seabrook, New Hampshire office. In his ...
(Date:6/5/2020)... ... 2020 , ... Greffex, a pioneering vaccine and gene therapy company based in ... the need for a global perspective to make an impact in a post pandemic ... serve as an independent, director of the company. , “The Greffex board is excited ...
(Date:5/28/2020)... (PRWEB) , ... May 27, 2020 , ... CrucialTrak, a ... partner with New Jersey-based Critical Environments Group (CEG) to market and sell its complete ... of data center and IT environment infrastructure optimization solutions . , Brett ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... Medrio, Inc., the leading provider ... has enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for ... first patient in (FPI) in just seven days. The Cytovale technology will allow ...
(Date:5/21/2020)... ... May 21, 2020 , ... Threats ... cause long-term harm , Contrary to conventional wisdom that says the coronavirus pandemic ... many companies will emerge from the pandemic commercially weaker, dealing with delays in ...
(Date:5/15/2020)... ... May 14, 2020 , ... Children with defective heart valves ... before becoming adults. The reason: there are no heart valve prosthetics designed to ... Department of Defense has awarded Draper, Boston Children’s Hospital and Seattle Children’s Research ...
(Date:5/14/2020)... ... May 13, 2020 , ... In collaboration with Sartorius, ... in the Life Science Lab . The comprehensive information source was created for ... and liquid handling to contamination control. , The content hub features the latest ...
Breaking Biology Technology: